References

1.Cunningham Jr., E.T.: Uveitis in children. Ocul. Immunol. Inflamm. 8(4), 251–261 (2000)

2.Jabs, D.A., Nussenblatt, R.B., Rosenbaum, J.T.: Standard­ ization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am. J. Ophthalmol. 140(3), 509–516 (2005)

3.Tugal-Tutkun, I., Havrlikova, K., Power, W.J., Foster, C.S.: Changing patterns in uveitis of childhood. Ophthalmology 103(3), 375–383 (1996)

4.Paivonsalo-Hietanen, T., Tuominen, J., Saari, K.M.: Uveitis in children: population-based study in Finland. Acta Oph­ thalmol. Scand. 78(1), 84–88 (2000)

5.Miyake, K.: Indomethacin in the treatment of postoperative cystoid macular edema. Surv. Ophthalmol. 28(suppl), 554–568 (1984)

6.Yannuzzi, L.A.: A perspective on the treatment of aphakic cystoid macular edema. Surv. Ophthalmol. 28(suppl), 540–553 (1984)

7.Jampol, L.M.: Pharmacologic therapy of aphakic cystoid macular edema. A review. Ophthalmology 89(8), 891–897 (1982)

8.Tso, M.O.M.: Cystoid macular edema. In: Tso, M.O.M. (ed.) Retinal diseases: biomedical foundations and clinical management. JB Lippincott, Philadelphia, PA (1988)

9.Henderly, D.E., Genstler, A.J., Rao, N.A., Smith, R.E.: Pars planitis. Trans. Ophthalmol. Soc. U. K. 105(pt 2), 227–232 (1986)

10.Smith, J.R.: Management of uveitis in pediatric patients: special considerations. Paediatr. Drugs 4(3), 183–189 (2002)

11.Vesterdal, E., Sury, B.: Iridocyclitis and bandshaped corneal opacity in juvenile rheumatoid arthritis. Acta Ophthalmol. (Copenh) 28(3), 321–335 (1950)

12.Sullivan, D.B., Cassidy, J.T., Petty, R.E.: Pathogenic implications of age of onset in juvenile rheumatoid arthritis. Arthritis Rheum. 18(3), 251–255 (1975)

13.Towner, S.R., Michet Jr., C.J., O’Fallon, W.M., Nelson, A.M.: The epidemiology of juvenile arthritis in Rochester, Minnesota 1960-1979. Arthritis Rheum. 26(10), 1208–1213 (1983)

14.Basic and Clinical Science Course. In: Moorthy, R.S. (ed) Intraocular Inflammation and Uveitis: Noninfectious (Auto­ immune) Uveitis, vol. 9. American Academy of Ophthal­ mology, San Francisco, CA (2007)

15.Kanski, J.J.: Juvenile arthritis and uveitis. Surv. Ophthalmol. 34(4), 253–267 (1990)

16.Basic and Clinical Science Course. In: Simon, J.W. (ed) Pediatric Ophthalmology and Strabismus: Uveitis in the Pediatric Age Group, vol. 6. American Academy of Ophthalmology, San Francisco, CA (2007)

17.Kanski, J.J.: Anterior uveitis in juvenile rheumatoid arthritis. Arch. Ophthalmol. 95(10), 1794–1797 (1977)

18.Anonymous: American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology: Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 92(2), 295–296 (1993)

19.Ohno, S., Char, D.H., Kimura, S.J., O’Connor, G.R.: HLA antigens and antinuclear antibody titres in juvenile chronic iridocyclitis. Br. J. Ophthalmol. 61(1), 59–61 (1977)

20.Monestier, M., Losman, J.A., Fasy, T.M., et al.: Antihistone antibodies in antinuclear antibody-positive juvenile arthritis. Arthritis Rheum. 33(12), 1836–1841 (1990)

21.Bloom, J.N., Ni, M., Moore, T.L., et al.: Serum antiocular antibodies in patients with juvenile rheumatoid arthritis.

J.Pediatr. Ophthalmol. Strabismus 30(4), 243–248 (1993)

22.Hunt, D.W., Petty, R.E., Millar, F.: Iris protein antibodies in serum of patients with juvenile rheumatoid arthritis and uveitis. Int. Arch. Allergy Immunol. 100(4), 314–318 (1993)

23.Sabates, R., Smith, T., Apple, D.: Ocular histopathology in juvenile rheumatoid arthritis. Ann. Ophthalmol. 11(5), 733–737 (1979)

24.Merriam, J.C., Chylack Jr., L.T., Albert, D.M.: Early-onset pauciarticular juvenile rheumatoid arthritis. A histopathologic study. Arch. Ophthalmol. 101(7), 1085–1092 (1983)

25.Weiss, A.H., Wallace, C.A., Sherry, D.D.: Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis [see comment]. J. Pediatr. 133(2), 266–268 (1998)

26.Malagon, C., Van Kerckhove, C., Giannini, E.H., et al.: The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: outcome in immunogenetically characterized patients. J. Rheumatol. 19(1), 160–163 (1992)

27.Dana, M.R., Merayo-Lloves, J., Schaumberg, D.A., Foster, C.S.: Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology 104(2), 236–244 (1997)

28.Sachs, J.A., Brewerton, D.A.: HLA, ankylosing spondylitis and rheumatoid arthritis. Br. Med. Bull. 34(3), 275–278 (1978)

29.Petty, R.E., Malleson, P.: Spondyloarthropathies of childhood. Pediatr. Clin. North Am. 33(5), 1079–1096 (1986)

30.Power, W.J., Rodriguez, A., Pedroza-Seres, M., Foster, C.S.: Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology 105(9), 1646–1651 (1998)

31.Hofley, P., Roarty, J., McGinnity, G., et al.: Asymptomatic uveitis in children with chronic inflammatory bowel diseases. J. Pediatr. Gastroenterol. Nutr. 17(4), 397–400 (1993)

32.Petty, R.E., Smith, J.R., Rosenbaum, J.T.: Arthritis and uveitis in children. A pediatric rheumatology perspective. Am. J. Ophthalmol. 135(6), 879–884 (2003)

33.Rodriguez, A., Akova, Y.A., Pedroza-Seres, M., Foster, C.S.: Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology 101(7), 1267–1274 (1994)

34.Taurog, J.D., el-Zaatari, F.A.: In vitro mutagenesis of HLAB27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes.

J.Clin. Invest. 82(3), 987–992 (1988)

35.Ebringer, A.: The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis. Br. J. Rheumatol. 22(4 Suppl 2), 53–66 (1983)

36.Ringrose, J.H.: HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27? Ann. Rheum. Dis. 58(10), 598–610 (1999)

37.Reveille, J.D.: HLA-B27 and the seronegative spondyloarthropathies. Am. J. Med. Sci. 316(4), 239–249 (1998)

38.Dodds, E.M., Lowder, C.Y., Meisler, D.M.: Posterior segment inflammation in HLA-B27+ acute anterior uveitis:

clinical characteristics [see comment]. Ocul. Immunol. Inflamm. 7(2), 85–92 (1999)

39.Dobrin, R.S., Vernier, R.L., Fish, A.L.: Acute eosinophilic interstitial nephritis and renal failure with bone marrowlymph node granulomas and anterior uveitis. A new syndrome. Am. J. Med. 59(3), 325–333 (1975)

40.Mandeville, J.T., Levinson, R.D., Holland, G.N.: The tubulointerstitial nephritis and uveitis syndrome [see comment]. Surv. Ophthalmol. 46(3), 195–208 (2001)

41.Goda, C., Kotake, S., Ichiishi, A., et al.: Clinical features in tubulointerstitial nephritis and uveitis (TINU) syndrome. Am. J. Ophthalmol. 140(4), 637–641 (2005)

42.Gafter, U., Kalechman, Y., Zevin, D., et al.: Tubulointerstitial nephritis and uveitis: association with suppressed cellular immunity. Nephrol. Dial. Transplant. 8(9), 821–826 (1993)

43.Iitsuka, T., Yamaguchi, N., Kobayashi, M., et al.: HLA tissue types in patients with acute tubulointerstitial nephritis accompanying uveitis. Nippon Jinzo Gakkai Shi. Jpn. J. Nephrol. 35(6), 723–731 (1993)

44.Sanchez Roman, J., Gonzalez Reina, I., Castillo Palma, M.J., Rocha Castilla, J.L.: Uveitis posterior asociada a nefritis tubulointersticial aguda con respuesta favorable a ciclosporina. Implicaciones patogenicas. Med. Clin. (Barc) 104(3), 118 (1995)

45.Gorrono-Echebarria,M.B.,Calvo-Arrabal,M.A.,Albarran,F., Alvarez-Mon, M.: The tuberculointerstitial nephritis and uveitis (TINU) syndrome is associated with HLA-DR14 in Spanish patients. Br. J. Ophthalmol. 85(8), 1010–1011 (2001)

46.Hirano, K., Tomino, Y., Mikami, H., et al.: A case of acute tubulointerstitial nephritis and uveitis syndrome with a dramatic response to corticosteroid therapy. Am. J. Nephrol. 9(6), 499–503 (1989)

47.Radig, H., Bialasiewicz, A.A., Gerding, H., Helmchen, U.: Tubulointerstitielle Nephritis und Uveitis (TINU-Syndrom). Ophthalmologe 89(5), 441–443 (1992)

48.Ellis, D., Fried, W.A., Yunis, E.J., Blau, E.B.: Acute interstitial nephritis in children: a report of 13 cases and review of the literature. Pediatrics 67(6), 862–870 (1981)

49.Sharma, O.P.: Sarcoidosis. Dis. Mon. 36(9), 469–535 (1990)

50.Siltzbach, L.E., James, D.G., Neville, E., et al.: Course and prognosis of sarcoidosis around the world. Am. J. Med. 57(6), 847–852 (1974)

51.Bresnitz, E.A., Strom, B.L.: Epidemiology of sarcoidosis. Epidemiol. Rev. 5, 124–156 (1983)

52.Rosenberg, A.M., Yee, E.H., MacKenzie, J.W.: Arthritis in childhood sarcoidosis. J. Rheumatol. 10(6), 987–990 (1983)

53.Shetty, A.K., Gedalia, A.: Sarcoidosis: a pediatric perspective. Clin. Pediatr. 37(12), 707–717 (1998)

54.Sahn, E.E., Hampton, M.T., Garen, P.D., et al.: Preschool sarcoidosis masquerading as juvenile rheumatoid arthritis: two case reports and a review of the literature. Pediatr. Dermatol. 7(3), 208–213 (1990)

55.Obenauf, C.D., Shaw, H.E., Sydnor, C.F., Klintworth, G.K.: Sarcoidosis and its ophthalmic manifestations. Am. J. Ophthalmol. 86(5), 648–655 (1978)

56.Hunter, D.G., Foster, C.S.: Ocular manifestations of sarcoidosis. In: Albert, D.M., Jakobiec, F.A. (eds.) Principles and Practice of Ophthalmology. Saunders, Philadelphia, PA (1994)

57.Johns, C.J., Scott, P.P., Schonfeld, S.A.: Sarcoidosis. Annu. Rev. Med. 40, 353–371 (1989)

58.Chan, C.C., Wetzig, R.P., Palestine, A.G., et al.: Immunohistopathology of ocular sarcoidosis.Report of a case and discussion of immunopathogenesis. Arch. Ophthalmol. 105(10), 1398–1402 (1987)

59.Rossman, M.D., Thompson, B., Frederick, M., et al.: HLADRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am. J. Hum. Genet. 73(4), 720–735 (2003)

60.Smith, M.J., Turton, C.W., Mitchell, D.N., et al.: Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax 36(4), 296–298 (1981)

61.Welch, R.B., Maumenee, A.E., Wahlen, H.E.: Peripheral posterior segment inflammation, vitreous opacities, and edema of the posterior pole. Arch. Ophthalmol. 64, 540–549 (1960)

62.Bonfioli, A.A., Damico, F.M., Curi, A.L., Orefice, F.: Intermediate uveitis. Semin. Ophthalmol. 20(3), 147–154 (2005)

63.Guest, S., Funkhouser, E., Lightman, S.: Pars planitis: a comparison of childhood onset and adult onset disease. Clin. Experiment. Ophthalmol. 29(2), 81–84 (2001)

64.Malinowski, S.M., Pulido, J.S., Folk, J.C.: Long-term visual outcome and complications associated with pars planitis. Ophthalmology 100(6), 818–824 (1993). discussion 25

65.Pederson, J.E., Kenyon, K.R., Green, W.R., Maumenee, A.E.: Pathology of pars planitis. Am. J. Ophthalmol. 86(6), 762–774 (1978)

66.Oruc, S., Duffy, B.F., Mohanakumar, T., Kaplan, H.J.: The association of HLA class II with pars planitis. Am. J. Ophthalmol. 131(5), 657–659 (2001)

67.Raja, S.C., Jabs, D.A., Dunn, J.P., et al.: Pars planitis: clinical features and class II HLA associations. Ophthalmology 106(3), 594–599 (1999)

68.Davis, J.L., Mittal, K.K., Nussenblatt, R.B.: HLA in intermediate uveitis. Dev. Ophthalmol. 23, 35–37 (1992)

69.Malinowski, S.M., Pulido, J.S., Goeken, N.E., et al.: The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology 100(8), 1199–1205 (1993)

70.Eichenbaum, J.W., Friedman, A.H., Mamelok, A.E.: A clinical and histopathological review of intermediate uveitis (“pars planitis”). Bull. N. Y. Acad. Med. 64(2), 164–174 (1988)

71.Green, W.R., Kincaid, M.C., Michels, R.G., et al.: Pars planitis. Trans. Ophthalmol. Soc. U. K. 101(pt 3)(3), 361–367 (1981)

72.Yoser, S.L., Forster, D.J., Rao, N.A.: Pathology of intermediate uveitis. Dev. Ophthalmol. 23, 60–70 (1992)

73.Kaplan, H.J.: Intermediate Uveitis (pars planitis, chronic cyclitis) – a four step approach to treatment. In: Saari, K.M. (ed.) Uveitis update. Excerpta medica, Amsterdam (1984)

74.Lynfield, R., Guerina, N.G.: Toxoplasmosis. Pediatr. Rev. 18(3), 75–83 (1997)

75.Frenkel, J.F.: Toxoplamosis: parasite life cycle, pathology, and immunology. In: Hammond, D.M., Long, P.L. (eds.) The Coccidia: eimeria, isospora, toxoplasma, and related genera. University Park Press, Baltimore, MD (1973)

76.Desmonts, G., Couvreur, J.: Congenital toxoplasmosis. A prospective study of 378 pregnancies. N. Engl. J. Med. 290(20), 1110–1116 (1974)

77.Desmonts, G., Couvreur, J.: Toxoplasmosis in pregnancy and its transmission to the fetus. Bull. N. Y. Acad. Med. 50(2), 146–159 (1974)

78.McMenamin, P.G., Dutton, G.N., Hay, J., Cameron, S.: The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis. Part I: The localization and morphology

of Toxoplasma cysts in the retina. Exp. Eye Res. 43(4), 529–543 (1986)

79.Rao, N.A., Font, R.L.: Toxoplasmic retinochoroiditis: elec- tron-microscopic and immunofluorescence studies of form- alin-fixed tissue. Arch. Ophthalmol. 95(2), 273–277 (1977)

80.Bosch-Driessen, L.E., Berendschot, T.T., Ongkosuwito, J.V., Rothova, A.: Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 109(5), 869–878 (2002)

81.Mets, M.B., Holfels, E., Boyer, K.M., et al.: Eye manifestations of congenital toxoplasmosis. Am. J. Ophthalmol. 122(3), 309–324 (1996)

82.Holland, G.N.: Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am. J. Ophthalmol. 136(6), 973–988 (2003)

83.Dodds, E.M.: Module 10: Ocular toxoplasmosis: clinical presentations, diagnosis, and therapy. Focal points: clinical modules for ophthalmologists. American Academy of Ophthalmology, San Francisco, CA (1999)

84.Rothova, A.: Ocular manifestations of toxoplasmosis. Curr. Opin. Ophthalmol. 14(6), 384–388 (2003)

85.Pinon, J.M., Dumon, H., Chemla, C., et al.: Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J. Clin. Microbiol. 39(6), 2267–2271 (2001)

86.Stepick-Biek, P., Thulliez, P., Araujo, F.G., Remington, J.S.: IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J. Infect. Dis. 162(1), 270–273 (1990)

87.Aouizerate, F., Cazenave, J., Poirier, L., et al.: Detection of Toxoplasma gondii in aqueous humour by the polymerase chain reaction. Br. J. Ophthalmol. 77(2), 107–109 (1993)

88.Bou, G., Figueroa, M.S., Marti-Belda, P., et al.: Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis. J. Clin. Microbiol. 37(11), 3465–3468 (1999)

89.Engstrom Jr., R.E., Holland, G.N., Nussenblatt, R.B., Jabs, D.A.: Current practices in the management of ocular toxoplasmosis. Am. J. Ophthalmol. 111(5), 601–610(1991)

90.Holland, G.N., Lewis, K.G.: An update on current practices in the management of ocular toxoplasmosis [erratum appears in Am J Ophthalmol 2002 Dec;134(6):944]. Am. J. Ophthalmol. 134(1), 102–114 (2002)

91.Stanford, M.R., See, S.E., Jones, L.V., Gilbert, R.E.: Antibiotics for toxoplasmic retinochoroiditis: an evidencebased systematic review [see comment]. Ophthalmology 110(5), 926–931 (2003). quiz 31–2

92.Pearson, P.A., Piracha, A.R., Sen, H.A., Jaffe, G.J.: Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology 106(1), 148–153 (1999)

93.McAuley, J., Boyer, K.M., Patel, D., et al.: Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial [erratum appears in Clin Infect Dis 1994 Oct;19(4):820]. Clin. Infect. Dis. 18(1), 38–72 (1994)

94.Loewer-Sieger, D.H., Rothova, A., Koppe, J.G., Kylstra, A.: Congenital toxoplasmosis, a prospective study based on 1821 pregnant women. In: Saari, K.M. (ed.) Uveitis update. Elsevier Science Publishers, Amsterdam (1984)

95.Wilder, H.C.: Nematode endophthalmitis. Trans. Am. Acad. Ophthalmol. Otolaryngol. 55, 99–109 (1950)

96.Shields, J.A.: Ocular toxocariasis. A review. Surv. Ophthalmol. 28(5), 361–381 (1984)

97.Glickman, L.T., Schantz, P.M.: Epidemiology and pathogenesis of zoonotic toxocariasis. Epidemiol. Rev. 3, 230–250 (1981)

98.Despommier, D.: Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin. Microbiol. Rev. 16(2), 265–272 (2003)

99.Molk, R.: Ocular toxocariasis: a review of the literature. Ann. Ophthalmol. 15(3), 216–219 (1983)

100.Stewart, J.M., Cubillan, L.D., Cunningham Jr., E.T.: Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina 25(8), 1005–1013 (2005)

101.Pollard, Z.F., Jarrett, W.H., Hagler, W.S., et al.: ELISA for diagnosis of ocular toxocariasis. Ophthalmology 86(5), 743–752 (1979)

102.Gillespie, S.H.: Human toxocariasis. J. Appl. Bacteriol. 63(6), 473–479 (1987)

103.Siam, A.L.: Toxocaral chorio-retinitis. Treatment of early cases with photocoagulation. Br. J. Ophthalmol. 57(9), 700–703 (1973)

104.Grand, M.G., Roper-Hall, G.: Pars plana vitrectomy for ocular toxocariasis. Retina 1(3), 258–261 (1981)

105.Hagler, W.S., Pollard, Z.F., Jarrett, W.H., Donnelly, E.H.: Resultsofsurgery forocularToxocaracanis.Ophthalmology 88(10), 1081–1086 (1981)

106.Maguire, A.M., Green, W.R., Michels, R.G., Erozan, Y.S.: Recovery of intraocular Toxocara canis by pars plana vitrectomy. Ophthalmology 97(5), 675–680 (1990)

107.Small, K.W., McCuen 2nd, B.W., de Juan Jr., E., Machemer, R.: Surgical management of retinal traction caused by toxocariasis. Am. J. Ophthalmol. 108(1), 10–14 (1989)

108.Adal, K.A., Cockerell, C.J., Petri Jr., W.A.: Cat scratch disease, bacillary angiomatosis, and other infections due to Rochalimaea. N. Engl. J. Med. 330(21), 1509–1515 (1994)

109.Jones, D.B.: Cat-scratch disease. In: Pepose, J.S., Holland, G.N., Wilhelmus, K.R. (eds.) Ocular infection and immunity. Mosby, St. Louis, MO (1996)

110.Margileth, A.M.: Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr. Infect. Dis. J. 11(6), 474–478 (1992)

111.Sweeney, V.P., Drance, S.M.: Optic neuritis and compressive neuropathy associated with cat scratch disease. Can. Med. Assoc. J. 103(13), 1380–1381 (1970)

112.Regnery, R.L., Anderson, B.E., Clarridge 3rd, J.E., et al.: Characterization of a novel Rochalimaea species, R. henselae sp. nov., isolated from blood of a febrile, human immunodeficiency virus-positive patient. J. Clin. Microbiol. 30(2), 265–274 (1992)

113.Cunningham, E.T., Koehler, J.E.: Ocular bartonellosis. Am. J. Ophthalmol. 130(3), 340–349 (2000)

114.Jackson, L.A., Perkins, B.A., Wenger, J.D.: Cat scratch disease in the United States: an analysis of three national databases. Am. J. Public Health 83(12), 1707–1711 (1993)

115.Koehler, J.E., Glaser, C.A., Tappero, J.W.: Rochalimaea henselae infection. A new zoonosis with the domestic cat as reservoir [see comment]. JAMA 271(7), 531–535 (1994)

116.Zangwill, K.M., Hamilton, D.H., Perkins, B.A., et al.: Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test [see comment].

N.Engl. J. Med. 329(1), 8–13 (1993)

117.Margileth, A.W., Wear, D.J., Hadfield, T.L., et al.: Catscratch disease. Bacteria in skin at the primary inoculation site. JAMA 252(7), 928–931 (1984)

118.Dreyer, R.F., Hopen, G., Gass, J.D., Smith, J.L.: Leber’s idiopathic stellate neuroretinitis. Arch. Ophthalmol. 102(8), 1140–1145 (1984)

119.Ormerod, L.D., Skolnick, K.A., Menosky, M.M., et al.: Retinal and choroidal manifestations of cat-scratch disease [see comment]. Ophthalmology 105(6), 1024–1031 (1998)

120.Reed, J.B., Scales, D.K., Wong, M.T., et al.: Bartonella henselae neuroretinitis in cat scratch disease. Diagnosis, management, and sequelae [see comment]. Ophthalmology 105(3), 459–466 (1998)

121.Wade, N.K., Levi, L., Jones, M.R., et al.: Optic disk edema associated with peripapillary serous retinal detachment: an early sign of systemic Bartonella henselae infection. Am.

J.Ophthalmol. 130(3), 327–334 (2000)

122.Solley, W.A., Martin, D.F., Newman, N.J., et al.: Cat scratch disease: posterior segment manifestations [see comment]. Ophthalmology 106(8), 1546–1553 (1999)

123.Suhler, E.B., Lauer, A.K., Rosenbaum, J.T.: Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis. Ophthalmology 107(5), 871–876 (2000)

124.Margileth, A.M.: Cat scratch disease. Adv. Pediatr. Infect. Dis. 8, 1–21 (1993)

125.Sander, A., Posselt, M., Bohm, N., et al.: Detection of Bartonella henselae DNA by two different PCR assays and determination of the genotypes of strains involved in histologically defined cat scratch disease. J. Clin. Microbiol. 37(4), 993–997 (1999)

126.Gass, J.D., Scelfo, R.: Diffuse unilateral subacute neuroretinitis. J. R. Soc. Med. 71(2), 95–111 (1978)

127.Gass, J.D., Braunstein, R.A.: Further observations concerning the diffuse unilateral subacute neuroretinitis syndrome. Arch. Ophthalmol. 101(11), 1689–1697 (1983)

128.Gass, J.D., Gilbert Jr., W.R., Guerry, R.K., Scelfo, R.: Diffuse unilateral subacute neuroretinitis. Ophthalmology 85(5), 521–545 (1978)

129.Cortez, R., Denny, J.P., Muci-Mendoza, R., et al.: Diffuse unilateral subacute neuroretinitis in Venezuela. Ophthalmology 112(12), 2110–2114 (2005)

130.Carney, M.D., Combs, J.L.: Diffuse unilateral subacute neuroretinitis. Br. J. Ophthalmol. 75(10), 633–635 (1991)

131.Gass, J.D., Callanan, D.G., Bowman, C.B.: Successful oral therapy for diffuse unilateral subacute neuroretinitis. Trans. Am. Ophthalmol. Soc. 89, 97–112 (1991). discussion 3–6

132.Wilhelmus, K.R.: The history of ocular syphilis. In: Bialasiwicz, A.A., Schall, K.P. (eds.) Infectious diseases of the eye. Eolus Press, Buren, The Netherlands (1994)

133.Wilhelmus, K.R., Lukehart, S.A.: Syphilis. In: Pepose, J.S., Holland, G.N., Wilhelmus, K.R. (eds.) Ocular infection and immunity. Mosby, St. Louis, MO (1996)

134.Deschenes, J., Seamone, C., Baines, M.: The ocular manifestations of sexually transmitted diseases. Can. J. Ophthalmol. 25(4), 177–185 (1990)

135.Sexually Transmitted Diseases Surveillance 2003. Centers for Disease Control and Prevention. Atlanta, GA: U.S. Department of Health and Human Services, September 2004.

136.Ingall, D , Sanchez, P., Baker, C J.: Syphilis. In: Remington, J.S., Llein, J.O. (eds.) Infectious diseases of the fetus and newborn infant, 6th edn. Elsevier Saunders, Philadelphia, PA (2006)

137. Aldave, A.J., King, J.A., Cunningham Jr., E.T.: Ocular syphilis. Curr. Opin. Ophthalmol. 12(6), 433–441 (2001)

138. Browning, D.J.: Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiency virus status on response [see comment]. Ophthalmology 107(11), 2015–2023 (2000)

139. Tamesis, R.R., Foster, C.S.: Ocular syphilis. Ophthalmology

97(10), 1281–1287 (1990)

140. Contreras, F., Pereda, J.: Congenital syphilis of the eye with lens involvement. Arch. Ophthalmol. 96(6), 1052–1053

(1978)